Delivery Order SPE2DB22D2206-SPE2DB25FJG45
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of AYVAKIT 200 mg tablets (30-count units) with a ceiling value of $24,403.80. This firm fixed-price delivery order, with an ultimate completion date of November 6, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award utilized no set-aside designation, indicating it was competitively...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,368.92 firm fixed-price delivery order is for AYVAKIT 25 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of July 7, 2025 and is not a set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for AYVAKIT 25 mg tablets (30-count units) on September 16, 2025, with a ceiling value of $48,737.84 and completion date of October 7, 2025. This firm fixed-price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999 through December 2026. The performance location is...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $19,064.80 to AmerisourceBergen Drug Corp on August 2, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at $999.99M and extends through December 2026. AmerisourceBergen, headquartered in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,780.60 to AmerisourceBergen Drug Corp on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order, issued under contract number 4569002076, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively made with no set-aside designation. AmerisourceBergen Drug Corp,...
- This federal contract award, valued at $24,131.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,038.72 on October 6, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which is not set-aside restricted, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The vendor, headquartered in Conshohocken, Pennsylvania, will...
- AmerisourceBergen Drug Corp was awarded a delivery order contract valued at $10,873.56 by the Defense Logistics Agency's Medical Supply Chain on August 11, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,083.60 to AmerisourceBergen Drug Corp on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. The award was competitively granted with no set-aside designation, reflecting the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $94,955.58 to AmerisourceBergen Drug Corp on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJG45Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of AYVAKIT 300 mg tablets (30-count) with a ceiling value of $24,675.50. This firm fixed-price delivery order, which is expected to be completed by August 27, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award carries no set-aside designation and was competitively awarded. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a critical federal vendor for military and veteran healthcare systems, with the parent IDC valued at $999,999,999.00 and running through December 2026. AmerisourceBergen's extensive portfolio of federal pharmaceutical contracts demonstrates the company's capability to fulfill diverse medical supply requirements across multiple therapeutic domains. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to deliver specialty medications, brand-name and generic drugs, vaccines, and related medical commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. This delivery order for AYVAKIT—a targeted cancer therapy—exemplifies the company's role as a key supplier within the DLA Medical Supply Chain's pharmaceutical procurement operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.7k | 8/6/25 |